BRCA2 and cancer: A total of 99 (63.5%) females were unaffected and underwent genetic testing because of a known familial BRCA1 or BRCA2 PV, whereas 57 (36.5%) had a cancer diagnosis; 51 (32.7%) had BC and 8 (5.1%) had OC.